Portalatin G, Hong-McAtee I, Burgner A, Gould E, Hunley T
Front Pediatr. 2025; 13:1521425.
PMID: 39950157
PMC: 11821607.
DOI: 10.3389/fped.2025.1521425.
Spellman 3rd M, Assaf T, Nangia S, Fernandez J, Nicholson K, Shepard B
Am J Physiol Renal Physiol. 2024; 327(6):F1013-F1025.
PMID: 39447117
PMC: 11687834.
DOI: 10.1152/ajprenal.00265.2024.
Xu B, Li S, Kang B, Fan S, Chen C, Li W
Mol Biol Rep. 2023; 50(11):9637-9647.
PMID: 37819499
DOI: 10.1007/s11033-023-08836-0.
Wiarda J, Becker S, Sivasankaran S, Loving C
J Anim Sci. 2022; 101.
PMID: 36183288
PMC: 9831138.
DOI: 10.1093/jas/skac318.
Klen J, Dolzan V
Int J Mol Sci. 2021; 22(18).
PMID: 34575958
PMC: 8466905.
DOI: 10.3390/ijms22189800.
Molecular characterization and nutritional regulation of sodium-dependent glucose cotransporter 1 (Sglt1) in blunt snout bream (Megalobrama amblycephala).
Liang H, Ge X, Ren M, Zhang L, Xia D, Ke J
Sci Rep. 2021; 11(1):13962.
PMID: 34234240
PMC: 8263726.
DOI: 10.1038/s41598-021-93534-9.
Sodium-Glucose Co-transporter-2 Inhibitors and Nephroprotection in Diabetic Patients: More Than a Challenge.
Provenzano M, Pelle M, Zaffina I, Tassone B, Pujia R, Ricchio M
Front Med (Lausanne). 2021; 8:654557.
PMID: 34150796
PMC: 8212983.
DOI: 10.3389/fmed.2021.654557.
Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application.
Gyimesi G, Pujol-Gimenez J, Kanai Y, Hediger M
Pflugers Arch. 2020; 472(9):1177-1206.
PMID: 32767111
PMC: 7462921.
DOI: 10.1007/s00424-020-02433-x.
Inherited Renal Tubulopathies-Challenges and Controversies.
Iancu D, Ashton E
Genes (Basel). 2020; 11(3).
PMID: 32150856
PMC: 7140864.
DOI: 10.3390/genes11030277.
Glucose transporters in the kidney in health and disease.
Vallon V
Pflugers Arch. 2020; 472(9):1345-1370.
PMID: 32144488
PMC: 7483786.
DOI: 10.1007/s00424-020-02361-w.
Acquired renal glucosuria in an undifferentiated connective tissue disease patient with a SLC5A2 heterozygous mutation: A case report.
Gu X, Chen M, Xu Y, Wang Y
Medicine (Baltimore). 2018; 97(50):e13664.
PMID: 30558067
PMC: 6319971.
DOI: 10.1097/MD.0000000000013664.
Inhibitor binding mode and allosteric regulation of Na-glucose symporters.
Bisignano P, Ghezzi C, Jo H, Polizzi N, Althoff T, Kalyanaraman C
Nat Commun. 2018; 9(1):5245.
PMID: 30532032
PMC: 6286348.
DOI: 10.1038/s41467-018-07700-1.
Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2.
Ghezzi C, Loo D, Wright E
Diabetologia. 2018; 61(10):2087-2097.
PMID: 30132032
PMC: 6133168.
DOI: 10.1007/s00125-018-4656-5.
Exploring glycosuria as a mechanism for weight and fat mass reduction. A pilot study with remogliflozin etabonate and sergliflozin etabonate in healthy obese subjects.
Napolitano A, Miller S, Murgatroyd P, Hussey E, Dobbins R, Bullmore E
J Clin Transl Endocrinol. 2017; 1(1):e3-e8.
PMID: 29235586
PMC: 5685025.
DOI: 10.1016/j.jcte.2013.12.001.
Novel and Unexpected Functions of SGLTs.
Wright E, Ghezzi C, Loo D
Physiology (Bethesda). 2017; 32(6):435-443.
PMID: 29021363
PMC: 5817162.
DOI: 10.1152/physiol.00021.2017.
Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart.
Van Steenbergen A, Balteau M, Ginion A, Ferte L, Battault S, De Meester de Ravenstein C
Sci Rep. 2017; 7:41166.
PMID: 28128227
PMC: 5269587.
DOI: 10.1038/srep41166.
MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2.
Coady M, El Tarazi A, Santer R, Bissonnette P, Sasseville L, Calado J
J Am Soc Nephrol. 2016; 28(1):85-93.
PMID: 27288013
PMC: 5198278.
DOI: 10.1681/ASN.2015111282.
Mutation in the Monocarboxylate Transporter 12 Gene Affects Guanidinoacetate Excretion but Does Not Cause Glucosuria.
Dhayat N, Simonin A, Anderegg M, Pathare G, Luscher B, Deisl C
J Am Soc Nephrol. 2015; 27(5):1426-36.
PMID: 26376857
PMC: 4849831.
DOI: 10.1681/ASN.2015040411.
Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences.
Gallo L, Wright E, Vallon V
Diab Vasc Dis Res. 2015; 12(2):78-89.
PMID: 25616707
PMC: 5886707.
DOI: 10.1177/1479164114561992.
Clinical and genetic analysis in a patient with primary renal glucosuria: Identification of a novel mutation in the gene.
Lee Y
Exp Ther Med. 2013; 6(6):1532-1534.
PMID: 24255686
PMC: 3829744.
DOI: 10.3892/etm.2013.1326.